2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association | Stroke
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial | The BMJ
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic Stroke | NEJM
Drugs in secondary stroke prevention
Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging | Scientific Reports
Current Recommendations for Secondary Stroke Prevention
JCM | Free Full-Text | Effectiveness of Platelet Function Analysis-Guided Aspirin and/or Clopidogrel Therapy in Preventing Secondary Stroke: A Systematic Review and Meta-Analysis
Life | Free Full-Text | Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic Stroke | NEJM
Ticagrelor, aspirin benefits in TIA outweigh risk over 30-day treatment period: Neurology
Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials - The Lancet
PDF) Aspirin Dosing for the Prevention and Treatment of Ischemic Stroke: An Indication-Specific Review of the Literature
Clopidogrel with Aspirin in Acute Minor Stroke or TIA | tctmd.com
THALES Secondary Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs
Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA | Semantic Scholar
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack | Neurology
Frontiers | Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
Cinnamon and Aspirin for Mild Ischemic Stroke or Transient Ischemic Attack: A Pilot Trial - ScienceDirect
Dual antiplatelet Tx for stroke prevention: Worth the risk? | MDedge Family Medicine
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack | Stroke
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar | Journal of the American College of Cardiology
Blogging Stroke – Role of Combined Clopidogrel and Aspirin in High-Risk TIA and Stroke: Discussing the POINT Trial
Aspirin Dosing for the Prevention and Treatment of Ischemic Stroke: An Indication-Specific Review of the Literature - Alexander J Ansara, Sarah A Nisly, Sally A Arif, Julia M Koehler, Sarah T Nordmeyer,
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic Stroke | NEJM
Stroke Guidelines | The International Aspirin Foundation
Abbreviations: ACS indicates acute coronary syndrome; TIA, transient... | Download Scientific Diagram
Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines | Stroke and Vascular Neurology
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
Dual antiplatelet Tx for stroke prevention: Worth the risk? | MDedge Family Medicine
![PDF] The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cfc35389ebc64406fddbc60b7c6a2d907ce71de1/3-Table1-1.png "PDF] The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design | Semantic Scholar")
PDF] The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design | Semantic Scholar
